Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome

New England Journal of Medicine

Volumn 370, Issue 5, 2014, Pages 486-488

  Giacomini, Paul S ^a   Rozenberg, Ayal ^a   Metz, Imke ^b   Araujo, David ^a   Arbour, Nathalie ^c   Bar Or, Amit ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MARAVIROC; NATALIZUMAB;

ADULT; APHASIA; BEHAVIOR; BRAIN RADIOGRAPHY; CASE REPORT; COGNITION; DRUG DOSE REDUCTION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS; LETTER; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SEIZURE; VIRUS LOAD;

EID: 84893099755     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1304828     Document Type: Letter

References (5)

1. Tan IL, McArthur JC, Clifford DB, Major EO, Nath A. Immune reconstitution inflammatory syndrome in natalizumabassociated PML. Neurology 2011;77:1061-7.
2. Antoniol C, Jilek S, Schluep M, et al. Impairment of JCVspecific T-cell response by corticotherapy: effect on PML-IRIS management? Neurology 2012;79:2258-64.
3. Schwab N, Höhn KG, Schneider-Hohendorf T, et al. Immunological and clinical consequences of treating a patient with natalizumab. Mult Scler 2012;18:335-44.
4. Delbue S, Elia F, Carloni C, et al. JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy. J Cell Physiol 2012;227:3511-7.
5. Yousry TA, Pelletier D, Cadavid D, et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2012;72:779-87.